Personalized medicine

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the personalized/precision medicine market

This dossier presents key facts and figures about developments in the personalized medicine segment - often called synonymously precision medicine. This document provides a closer look on preconditions, key data, the healthcare industry's view, and finally an outlook into the future.

Table of contents

  • 1. Premises
    • Patients without improvement after taking selected top selling drugs 2015

    • Share of patients for which a certain drug is ineffective by therapy class

    • Technological advances in the genome sequencing area 2003-2015

    • Technological advances in genomic medicine 2003-2015

    • Number of discovered genes with known disease-causing mutations 2003 and 2015

    • Patients whose tumors are driven by genetic mutations by cancer type 2016

    • Incidence of biomarker positivity cancer patients 2017 U.S. by type

  • 2. Biomarkers
    • U.S. development phase success rates for drugs with and without biomarkers 2006-2015

    • Biomarker technologies: global market 2015 and 2020

    • Total market size for biomarkers in the United States 2015-2024

    • Market size for biomarkers in the United States by disease 2015-2024

    • Market size for cancer biomarkers in the United States by application 2015-2024

    • Top sequencing companies worldwide by revenue 2017

  • 3. PM key data
    • Total global market for personalized medicine 2015-2022

    • Personalized medicine - investment growth 2006-2015

    • Number of personalized medicines in the U.S. 2008-2016

    • Personalized medicines as percent of new molecular entities 2014-2017

    • Personalized medicine in development by type 2015

  • 4. Views on PM
    • Healthcare professionals about their organization's focus 2016 vs. 2021

    • Healthcare organizations personalized medicine primary focus 2016 vs. 2018

    • U.S. adults that have not heard of personalized medicine 2018

    • Reactions among U.S. adults to description of personalized medicine 2018

    • U.S. opinions on insurance coverage of personalized tests and treatments in 2018

    • Major concerns among adults regarding personalized medicine in the U.S. in 2018

  • 5. Outlook
    • Global market for personalized medicine by product 2015-2022

    • Size of global DNA sequencing market in 2016 and 2023

    • Size of global companion diagnostics market 2014-2024

    • Global next generation sequencing market share forecast by technology 2024

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily. We are happy to help!